A phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignancies
Elisabeth I. Heath, Patricia LoRusso, Suresh S. Ramalingam, Ahmad Awada, Merrill J. Egorin, Tatiana Besse-Hamer, Fatima Cardoso, Manuel Valdivieso, Teresa Has, Leila Alland, Xiaofei Zhou, Chandra P. BТом:
29
Мова:
english
Сторінки:
6
DOI:
10.1007/s10637-010-9498-z
Date:
December, 2011
Файл:
PDF, 101 KB
english, 2011